intervenn.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: | ||
Meta Tags
| Title | InterVenn Biosciences | Clinical Glycoproteomics + Artificial |
| Description | Now we can see the full spectrum of our Clinical Glycoproteomics + Artificial |
| Keywords | ai,mass spectrometry,glycoproteomics |
Server Information
| WebSite | |
| Host IP | 141.193.213.11 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
intervenn.com Valuation
|
US$15,298,154
Last updated: 2023-05-08 13:41:14
intervenn.com has Semrush global rank of 691,868. intervenn.com has an estimated worth of US$ 15,298,154, based on its estimated Ads revenue. intervenn.com receives approximately 1,765,172 unique visitors each day. Its web server is located in United States, with IP address 141.193.213.11. According to SiteAdvisor, intervenn.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$15,298,154 |
| Daily Ads Revenue | US$14,122 |
| Monthly Ads Revenue | US$423,642 |
| Yearly Ads Revenue | US$5,083,695 |
| Daily Unique Visitors | 117,679 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| intervenn.com. | A | 299 | IP: 141.193.213.11 |
| intervenn.com. | A | 299 | IP: 141.193.213.10 |
| intervenn.com. | NS | 21600 | NS Record: ns-cloud-b4.googledomains.com. |
| intervenn.com. | NS | 21600 | NS Record: ns-cloud-b2.googledomains.com. |
| intervenn.com. | NS | 21600 | NS Record: ns-cloud-b1.googledomains.com. |
| intervenn.com. | NS | 21600 | NS Record: ns-cloud-b3.googledomains.com. |
| intervenn.com. | MX | 300 | MX Record: 10 alt4.aspmx.l.google.com. |
| intervenn.com. | MX | 300 | MX Record: 5 alt1.aspmx.l.google.com. |
| intervenn.com. | MX | 300 | MX Record: 10 alt3.aspmx.l.google.com. |
| intervenn.com. | MX | 300 | MX Record: 5 alt2.aspmx.l.google.com. |
| intervenn.com. | MX | 300 | MX Record: 1 aspmx.l.google.com. |
| intervenn.com. | TXT | 300 | TXT Record: google-site-verification=EHkc3q5-CSj4FuowBrn4lBHcgBlYiDev2mOCV0SV9Ho |
| intervenn.com. | TXT | 300 | TXT Record: v=spf1 include:_spf.google.com ~al |
HtmlToTextCheckTime:2023-05-08 13:41:14
| InterVenn Biosciences to Present Clinical Data on Circulating Serum Glycoproteins for Unprecedented Pre-Cancer Detection at Digestive Disease Week 2023 InterVenn Investigator Initiated Research Program in Glycoproteomics --> Products and Services --> Products and Services Products Services Science and Technology --> Science and Technology Enabling Technologies Glycoproteomics Publications For Investors --> For Investors For Investors News and Events Company --> Company About Us Leadership Team Careers Contact Now we can see the full spectrum of our health For 150 years, scientists have known that glycosylation—the process in which complex sugars are attached to proteins—can tell us about the development and progression of disease. Yet, glycosylation’s molecular complexity made it nearly impossible to study at scale or apply to our most urgent clinical needs. Until now. Discover Glycoproteomics High-resolution glycoproteomics InterVenn has developed the first |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 30 Oct 2021 03:45:14 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://intervenn.com/
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=%2FnGPZAD7ZSgUiFczZ1%2FqhpYY5M9BR5D6EwBnQhXwZHr7ejqX6zMqNo0em7SanJJ92aEsLnDWgN80BU8YJO9QR7etoMcJGdEjr%2FWPGOsplQSQZzErfj73XU7LBE5s9Wo%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a61a6519b57636c-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
HTTP/2 200
date: Sat, 30 Oct 2021 03:45:14 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
strict-transport-security: max-age=31536000; includeSubdomains; preload
content-security-policy: default-src 'self' 'unsafe-inline' 'unsafe-eval' https: data:
x-frame-options: SAMEORIGIN
x-xss-protection: 1; mode=block
x-content-type-options: nosniff
referrer-policy: no-referrer-when-downgrade
link:
|
intervenn.com Whois Information
Domain Name: INTERVENN.COM Registry Domain ID: 1917152277_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-04-07T12:34:48Z Creation Date: 2015-04-07T03:48:36Z Registry Expiry Date: 2022-04-07T03:48:36Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-CLOUD-B1.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-B2.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-B3.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-B4.GOOGLEDOMAINS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T14:50:52Z <<< |